Amy Schofield

879 POSTS 0 COMMENTS
Amy is Special Editions Editor at Pharmafield. She is an experienced journalist and editor of both digital and print content across healthcare, technology and careers. 

Latest articles

NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy

EC grants marketing authorisation for breast cancer treatment Trodelvy

The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
People standing in a lab in front of computer screens containing data to show Overcoming the challenges to making data FAIR in pharma

Sales excellence within a value-based promotional model

Forward thinking brand teams are developing a value-based promotional model to promote products in a way which is perceived as offering real differentiation In 2006,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription